Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

ClinicalTrials.gov ID: NCT01018173

Public ClinicalTrials.gov record NCT01018173. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 5:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This randomized, double-blind, placebo-controlled parallel arm study will assess efficacy and safety and the effects of taspoglutide on cardiovascular events in patients with inadequately controlled type 2 diabetes mellitus and established cardiovascular disease. Patients will be randomized to receive either taspoglutide subcutaneously (sc) 10mg weekly for 4 weeks followed by 20mg sc weekly, or weekly sc placebo, in addition to background anti-hyperglycemic medication and standard of care treatment for cardiovascular disease. Anticipated time on study treatment is up to 2 years. Target sample size is 2000 patients.

Study identification

NCT ID
NCT01018173
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
2,118 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2009
Primary completion
Dec 31, 2010
Completion
Dec 31, 2010
Last update posted
Nov 1, 2016

2010 – 2011

United States locations

U.S. sites
76
U.S. states
27
U.S. cities
70
Facility City State ZIP Site status
Not listed Phoenix Arizona 85050
Not listed Tucson Arizona 85741
Not listed Buena Park California 90620
Not listed Calabasas California 91302
Not listed Fresno California 93720
Not listed Santa Ana California 92705
Not listed Walnut Creek California 94598
Not listed Centennial Colorado 80112
Not listed Colorado Springs Colorado 80907
Not listed Trumbull Connecticut 06611
Not listed Washington D.C. District of Columbia 20010
Not listed Clearwater Florida 33765
Not listed Delray Beach Florida 33446
Not listed Jacksonville Florida 32216
Not listed Miami Florida 33126
Not listed Ponte Verde Florida 32081
Not listed Bloomingdale Illinois 60108
Not listed Chicago Illinois 60607
Not listed Chicago Illinois 60610
Not listed Evansville Indiana 47714
Not listed Baltimore Maryland 21204
Not listed Oxon Hill Maryland 20745
Not listed Jackson Mississippi 39202
Not listed St Louis Missouri 63141
Not listed North Platte Nebraska 69101
Not listed Omaha Nebraska 68131
Not listed Las Vegas Nevada 89101
Not listed Las Vegas Nevada 89104
Not listed Nashua New Hampshire 3063
Not listed Toms River New Jersey 08753
Not listed Mineola New York 11501
Not listed New York New York 10032
Not listed Calabash North Carolina 28467
Not listed Cary North Carolina 27518
Not listed Chapel Hill North Carolina 27514
Not listed Charlotte North Carolina 28209
Not listed Durham North Carolina 27713
Not listed Mooresville North Carolina 28117
Not listed Raleigh North Carolina 27607
Not listed Bismarck North Dakota 58501
Not listed Bismarck North Dakota 58507
Not listed Cleveland Ohio 44122
Not listed Kettering Ohio 45429
Not listed Toledo Ohio 43623
Not listed Bend Oregon 97701
Not listed Medford Oregon 97504
Not listed Portland Oregon 97229
Not listed Beaver Pennsylvania 15009
Not listed Levittown Pennsylvania 19056
Not listed Philadelphia Pennsylvania 19140
Not listed Pottstown Pennsylvania 19464
Not listed Greer South Carolina 29651
Not listed Hickory Grove South Carolina 28602
Not listed Bristol Tennessee 37620
Not listed Johnson City Tennessee 37604
Not listed Austin Texas 78705
Not listed Carrollton Texas 75010
Not listed Dallas Texas 75220
Not listed Dallas Texas 75230
Not listed Dallas Texas 75246
Not listed Fort Worth Texas 76109
Not listed Houston Texas 77070
Not listed Irving Texas 75039
Not listed North Richland Hills Texas 76180
Not listed Richardson Texas 75080
Not listed San Antonio Texas 78229-4801
Not listed San Antonio Texas 78229
Not listed Temple Texas 76508
Not listed Salt Lake City Utah 84107
Not listed Burke Virginia 22015
Not listed Hampton Virginia 23666
Not listed Manassas Virginia 20110
Not listed Norfolk Virginia 23502
Not listed Richmond Virginia 23219
Not listed Winchester Virginia 22601
Not listed Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 212 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01018173, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 1, 2016 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01018173 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →